Foley Hoag LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Foley Hoag LLP guides innovators through the full product and company lifecycle, combining corporate, IP, regulatory and disputes. Working in combination with the life sciences team, the transactional team structures high-value, often cross-border collaborations and financings, while the IP team protects and leverages market‑leading assets, managing global portfolios for clients across pharma, tech, digital health and biotech. Co-chair of the life sciences industry group Amy Baker-Mandragouras advises life sciences companies on IP strategy, portfolio management, and high-stakes transactions. Alongside her, co-chair Jeffrey Quillen serves a number of emerging biotech, software and information technology companies, negotiating and drafting agreements regarding IP rights, including patent license agreements. Both lawyers mentioned above are based in Boston.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team at Foley has been our go to firm for our most important IP filings for years now. They are very strong both technically and in terms of their worldwide patent practice-related expertise. Their customer service is excellent and extremely responsive.’
Key clients
- AbbVie, Inc., Pharmacyclics LLC, Allergan plc
- Alexion Pharmaceuticals, Inc.